Value of 2-[18F]-Fluoro-2-Deoxy-D-Glucose Imaging With Dual-Head Gamma Camera in Coincidence Mode
Authors:
- Dheeraj GandhiDGDheeraj Gandhi
- Steve FalenSFSteve Falen
- William McCartneyWMWilliam McCartney
- William ShockleyWSWilliam Shockley
- Mark WeisslerMWMark Weissler
- Sylvia WrennSWSylvia Wrenn
- Gaurang ShahGSGaurang Shah
- Suresh K MukherjiSMSuresh K Mukherji
- 1 July 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 29 (4) , 513-519
Abstract
The aim of the present study was to assess the value of dual-head gamma-camera (DHGC) imaging in the coincidence mode using 2-[18F]-fluoro-2-deoxy-D-glucose in differentiating recurrent tumor from posttreatment changes in previously treated head and neck cancer. This was a single-center prospective study performed with the approval of our Institutional Review Board. Twenty-nine patients with suspected recurrent head and neck cancers were prospectively enrolled in this study. Dual-head gamma-camera imaging in the coincidence mode followed computed tomography (CT; n = 24)/magnetic resonance imaging (MRI; n = 5) within a period of 1 week (mean = 3.5 days) in all patients. Thirteen patients had definite pathologic confirmation of recurrence by undergoing a biopsy. Sixteen patients, however, did not have a definite pathologic confirmation and were followed clinically. The mean duration of follow-up for the subgroup of patients who were followed clinically was 22.8 months (range: 4-48 months). Sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) for CT/MRI and DHGC imaging in the coincidence mode were calculated. The sensitivity, specificity, PPV, NPV, and accuracy of CT/MRI in the detection of recurrent cancer were 76.5%, 58.3%, 72.2%, 63.6%, and 69%, respectively. In contrast, the sensitivity (100%), NPV (100%), and accuracy (82.8%) of DHGC imaging in the coincidence mode were superior to that of CT/MRI. Dual-head gamma-camera imaging in the coincidence mode had a specificity (58.3%) and PPV (77.3%) comparable to those of CT/MRI. Our data suggest that modified positron emission tomography with DHGC imaging in the coincidence mode is a useful tool in the assessment of recurrent head and neck cancer.Keywords
This publication has 21 references indexed in Scilit:
- Gamma camera coincidence imaging with [18F]fluorodeoxyglucose in the pretreatment evaluation of patients with oesophageal cancerNuclear Medicine Communications, 2003
- Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PETBritish Journal of Radiology, 2002
- The clinical value of 18F-FDG detection with a dual-head coincidence camera: a reviewEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methodsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Value of Iterative Reconstruction, Attenuation Correction, and Image Fusion in the Interpretation of FDG PET Images with an Integrated Dual-Head Coincidence Camera and X-Ray-based Attenuation MapsRadiology, 2001
- Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic PatientThe Laryngoscope, 2000
- The detection of local recurrent head and neck cancer with fluroine-18 fluorodeoxyglucose dual-head positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapyHead & Neck, 1994
- Elevated Levels of Glucose Transport and Transporter Messenger RNA Are Induced by ras or src OncogenesScience, 1987
- Computed tomography of the neck in the postoperative patient: radical neck dissection and the myocutaneous flap.Radiology, 1983